1. Home
  2. PEN vs MORN Comparison

PEN vs MORN Comparison

Compare PEN & MORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEN
  • MORN
  • Stock Information
  • Founded
  • PEN 2004
  • MORN 1984
  • Country
  • PEN United States
  • MORN United States
  • Employees
  • PEN N/A
  • MORN N/A
  • Industry
  • PEN Medical/Dental Instruments
  • MORN Investment Managers
  • Sector
  • PEN Health Care
  • MORN Finance
  • Exchange
  • PEN Nasdaq
  • MORN Nasdaq
  • Market Cap
  • PEN 10.6B
  • MORN 10.9B
  • IPO Year
  • PEN 2015
  • MORN 2005
  • Fundamental
  • Price
  • PEN $272.98
  • MORN $257.14
  • Analyst Decision
  • PEN Strong Buy
  • MORN Buy
  • Analyst Count
  • PEN 16
  • MORN 3
  • Target Price
  • PEN $302.93
  • MORN $361.67
  • AVG Volume (30 Days)
  • PEN 471.2K
  • MORN 359.5K
  • Earning Date
  • PEN 10-29-2025
  • MORN 10-22-2025
  • Dividend Yield
  • PEN N/A
  • MORN 0.71%
  • EPS Growth
  • PEN 916.05
  • MORN 64.83
  • EPS
  • PEN 3.74
  • MORN 9.41
  • Revenue
  • PEN $1,280,152,000.00
  • MORN $2,347,400,000.00
  • Revenue This Year
  • PEN $15.52
  • MORN $8.04
  • Revenue Next Year
  • PEN $14.20
  • MORN $7.65
  • P/E Ratio
  • PEN $72.95
  • MORN $27.34
  • Revenue Growth
  • PEN 12.92
  • MORN 8.23
  • 52 Week Low
  • PEN $184.80
  • MORN $249.56
  • 52 Week High
  • PEN $310.00
  • MORN $365.00
  • Technical
  • Relative Strength Index (RSI)
  • PEN 56.68
  • MORN 42.75
  • Support Level
  • PEN $270.54
  • MORN $249.56
  • Resistance Level
  • PEN $288.91
  • MORN $258.80
  • Average True Range (ATR)
  • PEN 7.36
  • MORN 4.60
  • MACD
  • PEN -0.15
  • MORN 0.65
  • Stochastic Oscillator
  • PEN 41.57
  • MORN 46.88

About PEN Penumbra Inc.

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.

About MORN Morningstar Inc.

Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.

Share on Social Networks: